A new human adipocyte model with PTEN haploinsufficiency

Abstract

Few human cell strains are suitable and readily available as in vitro adipocyte models. We used resected lipoma tissue from a patient with germline phosphatase and tensin homolog (PTEN) haploinsufficiency to establish a preadipocyte cell strain termed LipPD1 and aimed to characterize cellular functions and signalling pathway alterations in comparison to the established adipocyte model Simpson-Golabi-Behmel-Syndrome (SGBS) and to primary stromal-vascular fraction cells. We found that both cellular life span and the capacity for adipocyte differentiation as well as adipocyte-specific functions were preserved in LipPD1 and comparable to SGBS adipocytes. Basal and growth factor-stimulated activation of the PI3 K/AKT signalling pathway was increased in LipPD1 preadipocytes, corresponding to reduced PTEN levels in comparison to SGBS cells. Altogether, LipPD1 cells are a novel primary cell model with a defined genetic lesion suitable for the study of adipocyte biology. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Description
Keywords
Citation
Kässner F., Kirstein A., Händel N., Schmid G.L., Landgraf K., Berthold A., et al. (2020). A new human adipocyte model with PTEN haploinsufficiency (Abingdon : Taylor and Francis Inc.). Abingdon : Taylor and Francis Inc. https://doi.org//10.1080/21623945.2020.1785083
Collections
License
CC BY-NC 4.0 Unported